Connected Health: Revolutionizing Patient Care Through Artificial Intelligence Innovations

Abstract

The pharmaceutical sector is not immune to the radical changes brought about by the widespread adoption of AI. Automation, optimisation, and individualization are just some of the ways that artificial intelligence is being applied in the pharmaceutical business, from drug research to dispensing. This article examines how AI is already being used and where it has the potential to go in the pharmaceutical sector. We'll take a look at how AI is being used in the pharmaceutical industry, from R&D to personalised medicine to quality assurance to supply chain management to patient counselling. Data privacy, ethical concerns, and legal impediments are just a few of the difficulties we'll cover in relation to the use of AI in the pharmaceutical industry. This article will highlight studies that demonstrate how AI has the potential to drastically revolutionise the pharmaceutical industry through accelerating medicine development, improving patient outcomes, lowering costs, and increasing efficiency and accuracy across the board. This has led many to predict that AI will revolutionise every aspect of healthcare, from diagnosis to treatment to follow-up care. In most people's minds, AI techniques will supplement and improve upon existing human efforts rather than supplant them. Artificial intelligence is prepared to assist the healthcare business with administrative work, clinical documentation, patient outreach, and specialised aid in areas such as image analysis, medical device automation, and patient monitoring.